Telemedicina y telesalud: cómo COVID 19 ha transformado la atención del cáncer En este video de discusión, el Dr. Narjust Duma habla con los Dres...
¿Qué sabemos sobre los efectos del COVID-19 en latinos con cáncer? Actualizaciones y recomendaciones. En este video de discusión, el Dr. Narjust Duma...
(SPANISH) ¿Cómo ha afectado el COVID-19 el diagnóstico de cáncer y qué puede hacer usted al respecto? Es hora de recordar la importancia de la...
From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired...
In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26...
Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...
Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...
Hello, I was diagnosed with stage 4 lung cancer on September 5, 2024, at 36 years old. I initially had a persistent cough and was told it was...
Hello I'm 30 years old and have been a smoker for 15 years. Around this time last year (November/December), I started experiencing occasional chest...
Hello, Has anyone watched the Lung Cancer OncTalk 2024 On Demand sessions yet? I’m curious if the content offers any new insights or updates compared...
En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras.
Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum!
The full unedited versions of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage and Second Stage, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks.
Apply Online Now for this paid opportunity to tell your story!
Apply Online Now for this paid opportunity to tell your story!
GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview
If you want to keep up on what content GRACE is producing, or if there is a specific program you are interested in seeing throughout the years, there are many ways to find that information. One of the best tools is the navigation drop-down under EDUCATE.
Just found this site and am looking for some information about lung IMA. I was diagnosed May, 2020 and had left lower lung lobectomy. The tumor was small relatively 1.7cm x 1.0 cm (it had doubled in size following an incidental CT for kidney stone in 2019). No lymphatic, vascular or pleural spread but there was STAS. ,It was a solitary tumor, not the pneumatic type. My thoracic surgeon is following with every 6 month scans. So my next scan coming up in June will be 24 months cancer free, hopefully.
I am inquiring on behalf of my sister-in-law who was diagnosed with stage three colon and rectal cancer in July 2020. She is 53 years old and a former smoker. She underwent chemotherapy for six months, followed by six weeks of radiation, and in April 2020 she had surgery to remove the tumor in her sigmoid. At that time, 17 od her lymph nodes were removed and all were clear, so she was restaged to stage two.
We had an overwhelming response to our call for clinical trial participants who would be interested in creating educational content for others by sharing their experiences!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.